Τόμος 17 (2003) – Τεύχος 1 – Άρθρο 4 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 17 (2003) – Issue 1 – Article 4 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

 

Title Nurses attitudes and ethical dilemmas regarding hepatitis B and hepatitis B virus carriers
Authors P. Iordanou¹ and M. Noula²

1.   Nursing Department, Technological Educational Institution (TEI) of Athens, Athens, Greece

2.   Nursing Field in Secondary Education, Athens, Greece

Citation Iordanou, P., Noula, M.: Nurses attitudes and ethical dilemmas regarding hepatitis B and hepatitis B virus carriers, Epitheorese Klin. Farmakol. Farmakokinet. 17(1): 37-41 (2003)
Publication Date  May 2003
Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €) 

pharmakonpress[at]pharmakonpress[.]gr

Keywords Hepatitis B, nurses’ attitudes, ethical dilemmas, barriers, vaccine.
Other Terms review article
Summary This study was conducted among 696 subjects-nurses in five hospitals to examine their attitudes and ethical dilemmas concerning the provision of nursing care to patients-clients with hepatitis B (HB) and HB virus and to identify any barriers they perceived in safety. More than the half of the nurses, 56.2% (345) stated that had been vaccinated against HB. A fair number, 63.7% (441) nurses stated that it was not a dilemma for them to provide care to patients with HB. As barriers were identified the lack of adequate protecting measures from 57% (143) nurses. Gloves considered important in the protection of nurses, 94.7% (692) nurses stated that they ought to wear gloves during blood drawing or blood and intravenous administration, and 93.5% (651) when a blood transfusion was given. Fear of transmission of HB was stated from 53% (133) of nurses and fear of transmission of HB to nurses’ children (through nurses as mothers) from 29.5% (74). Greater number of vaccinated nurses stated that had not dilemmas to care for patients with HB (p=0.048). In order, to control their own risk and provide patient-clients care without dilemmas and fears of transmission, nurses must remain alert and aware of risk factors, of the barriers, of the standards that are being trusted upon them being supported by the institutions-hospitals and the public must provide them all basic protective measures.
References 1.    Kane M., Ghendon Y., Lambert PH.: Where are we: the WHO program for control of viral hepatitis. In: (Hollinger F.B., Lemon S.M., Margolis H.S., eds) Viral Hepatitis and Liver Disease. Pp. 706-708, Williams and Wilkins, Baltimore, 1991

2.    Grosheide P., Van Damme P.: Prevention and control of hepatitis B in the community. In: (Hallauer J., Kane MA., McCioy E., Mcheus A., Roure C., eds) Communicable Diseases Series No. 1. Antwerp: Viral Hepatitis Prevention Board, University of Antwerp, 1996

3.    Centers for Disease Control: Inactivated hepatitis B virus vaccine: recommendations of the Immunization Practices Advisory Committee. MMWR: 317-322, 327-328 (1982)

4.    Mahoney F., Stewart K., Hu H., Alter M.J.: Progress towards elimination of hepatitis B virus transmission among health care workers in the United States. Arch. Int. Med.: 2601-2605 (1998)

5.    Bonanni P., Crovani P. Success stories in the implementation of universal hepatitis B vaccination: an update on Italy. Vaccine 16(Suppl.): S38-S42 (1998)

6.    http://www.nursingword. org/pressrel/2001/pr0418a.htm

7.    VHPB. Hepatitis B as an Occupational Hazard. European Occupational Health Series No. 8. Copenhagen: WHO Regional Office for European. P. 64,1994

8.    VHPB: Viral Hepatitis, Vol. 1, Issues 1-3. London: Medical Imprint, 1992

9.    Hallauer J., Kane M., McCioy E. (Editors): Eliminating Hepatitis B as an Occupational Hazard. P. 114 London: Medical Imprint, 1993

10.  McCioy E.: Evolution of the Viral Hepatitis Prevention Board. Vaccine 13(Suppl 1): S7-S8 (1995)

11.  Van Damme P., Tormans G., Van Doorslaer E., Kane M., Roure C., Meheus A.: A European risk model for hepatitis B among health care workers. Eur. J. Public Health 5: 245-252 (1995)

12.  Ayyat A.A., Sayed H.A., Abou Had A.M.: A KAP study among staff and student nurses about infection control in Theodor Bilharz Hospital. J. Egypt Soc. Parasitol. (30) Issue Part Supplement (2): 511-522 (2000)

13.  Barrigar D., Flagel D., Upshur R.: Hepatitis B virus infected physicians and disclosure of transmission risk to patients: A critical analysis. BMC Medical Ethics 2: 4-10 (2001)

14.  Ristinen E., Mamtani R.: Ethics of transmission of hepatitis B virus by health care workers. Lancet 352: 1381- 1384 (1998)

15.  http://www.nursingword.org/read room/position/blood/blhvrn.htm.2003 Position statements. HIV Infected Nurses, Ethical Obligation and disclosure

16.  Cipriano M., Ludwick R.: Interstate Nursing Practice and Regulation: Ethical Issues for 21st Century. Online Journal of issues in Nursing. Pp. 1-4, 1999

17.  Beauchamp T.L., Childress J.F.: Principles of biomedical ethics. P. 192, 4th ed., Oxford University Press, New York, 1964

18.  Lockheel Martin Corporation: Maintaining ethical conduct throughout an organization. Health System Leader: 26-27 (1997)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2003– ANNUAL SUBSCRIPTION 2003
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

 

 

 

Bookmark the permalink.

Comments are closed.